MedTrace Logo

Personalized Outreach for Equitable Treatment in Rheumatology

NCT07022756 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2025-07-04

No results posted yet for this study

Summary

The primary goal of this study is to determine whether providing patient honoraria and/or outreach services can improve the attendance rate of appointments at an inner city rheumatology clinic in Vancouver, British Columbia.

The main question it aims to answer are:

* Does providing a financial honorarium ($20 for each follow-up appointment with completed bloodwork) improve attendance rate at an inner city rheumatology clinic?
* Does providing a personalized outreach service for rheumatic diseases improve attendance rate at an inner city rheumatology clinic?

The researchers will compare providing patient honoraria to providing both honoraria and outreach services, and compare each of these to the regular appointment schedule without honoraria or outreach.

Participants will:

* Undergo randomization to receive honoraria or honoraria and outreach services together
* Complete surveys about their health and understanding of their rheumatic disease at baseline, 3-month, and 6-month intervals
* Visit the clinic every month for check-ups and monitoring bloodwork if they are started on immunosuppressants for their condition

Conditions

  • Rheumatic Diseases
  • Inflammatory Arthritis
  • Rheumatoid Arthritis (RA)
  • Psoriatic Arthritis (PsA)
  • Connective Tissue Disease

Interventions

BEHAVIORAL

Honoraria

A $20 honorarium for each appointment attended with completed bloodwork if requested.

BEHAVIORAL

Outreach

A personalized outreach service specific for rheumatic disease.

Sponsors & Collaborators

  • Mary Pack Arthritis Center

    collaborator UNKNOWN

  • University of British Columbia

    lead OTHER

Principal Investigators

  • Brent R Ohata, MD · University of British Columbia

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-02
Primary Completion
2026-04-30
Completion
2026-06-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07022756 on ClinicalTrials.gov